Arkolith/Insider Trading/CKPT/Form 4

Oliviero James F III

CEO, President and Director, DirectorCheckpoint Therapeutics, Inc. (CKPT) · full profile →Form 4 · filed Feb 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$64K
Net Open-Market Flow
-$64K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 10, 2025Sell(S)10K$3.15$33K3.8M
Feb 7, 2025Sell(S)9K$3.41$31K3.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-011656) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML